Litcius/Paper detail

Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma

Darren Pan, Joshua Richter

2024Current Hematologic Malignancy Reports21 citationsDOI

Topics & Concepts

MedicineBispecific antibodyAntibodyMultiple myelomaAdverse effectHematologyCytokine release syndromeImmunologyOncologyImmunotherapyInternal medicineMonoclonal antibodyChimeric antigen receptorImmune systemCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchMultiple Myeloma Research and Treatments
Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma | Litcius